Ocular inflammation from various causes may have similar clinical presentation thus careful clinical evaluations are mandatory particularly when the disease appear to be resistant to treatment. This paper reports a case of ocular lymphoma which was initially treated as Vogt Koyanagi Harada disease at a different centre. A 65-year-old Sudanese man complained of gradual worsening left eye vision. Careful ocular and slit lamp examination revealed a conjunctival lesion with choroidal infiltration as well as exudative retinal detachment. Computed tomography scan (CT scan) showed left eye axial proptosis, and a homogenous enhancing mass at the posterior coat of the globe. Tissue biopsy of the conjunctival lesion revealed marginal Zone B cell (MALT type), low grade, non-Hodgkin’s lymphoma. AS the ocular signs and symptoms progressed, chemotherapy was initiated. The proptosis, exudative retinal detachment, disc hyperemia and swelling improved after chemotherapy. The post treatment CT scan showed reduction of the posterior ocular coat mass. The possibility of malignant lymphoma should be considered in patients with resistant uveitis despite administration of corticosteroid. Ocular lymphoma is an indolent tumour with good prognosis. Careful ocular examination, adequate imaging studies followed by early surgical biopsy will contribute to early diagnosis.
Uveomeningoencephalitic Syndrome

No abstract available.
Hearing Loss* ; Hearing* ; Uveomeningoencephalitic Syndrome*

No abstract available.
Adalimumab ; Adult ; Female ; Humans ; Uveomeningoencephalitic Syndrome

We have experienced a case of Vogt-Koyanagi-Harada Syndrome in 35 years-old male. The Voght-Koyanagi-Harada Syndrome is characterized by severe chronic bilateral Ilveitis associated with alopecia, poliosis, vitiligo and signs of meningeal irritation. In presented case, there was extensive posteriar synechia, numerous mutton fat K.P. in addition to cataract, poliosis, vitiligo, headache and dysacousia. Steroid was administered over period of 6 monthes in gradual decreasing dosage, but there was no appearent effect on the course of the disease.
Adult ; Alopecia ; Cataract ; Headache ; Humans ; Male ; Uveomeningoencephalitic Syndrome* ; Vitiligo

VKH syndrome is a symptom complex having prodromal systemic manifestations, bilateral uveites and exudative retinal detachment. It has not been known clearly whether it is relelated to DM or not. We experienced a 43-year old man complaining of acutely decreased visual acuity in both eyes with bilateral choroidal detachment. He has been diabetic for 5 years in uncontrolled state. He was diagnosed to have VKH syndrome and was treated with local steroid injection with visual improvement. So we present this case with review of literatures.
Adult ; Choroid* ; Humans ; Retinal Detachment ; Uveomeningoencephalitic Syndrome ; Visual Acuity

Besides meningism, dizziness has also been frequently reported as a neurologic manifestation of Vogt- Koyanagi-Harada(VKH) syndrome. These neurotologic symptoms usually develop just before or after ocular involvement. We report the patient with VKH syndrome who showed recurrent peripheral vertigo. The characteristic opthalmological symptoms developed later in this case.
Dizziness ; Humans ; Meningism ; Neurologic Manifestations ; Uveomeningoencephalitic Syndrome* ; Vertigo*

PURPOSE: We analyzed the clinical features of patients with recurrent Vogt-Koyanagi-Harada(VKH) syndrome. METHODS: A retrospective chart review of 21 patients diagnosed with VKH syndrome between 1994 and 2004 was performed. We grouped the patients into two groups according to the duration of ocular inflammation. Group A included patients with recurrent ocular inflammation lasting 24 months or longer and Group B included those with a duration of less than 24 months. We compared the clinical manifestations, responses to treatment and complications. RESULTS: Group A had 7 patients and Group B had 14 patients. There were significant differences in initial visual acuity, the interval between ocular symptoms and treatment, total steroid dose, and complications. The average final visual acuity of Group A was 0.572 (0.2-1.0), which was relatively favorable. CONCLUSIONS: The initial visual acuity and the interval between ocular symptoms and treatment seemed to be important predictors. We conclude that aggressive treatment is necessary in recurrent VKH syndrome, as visual prognosis was relatively favorable despite the cost of the problems associated with high dose steroids and ocular complications.
Humans ; Inflammation ; Prognosis ; Retrospective Studies ; Steroids ; Uveomeningoencephalitic Syndrome* ; Visual Acuity

Clinical records of 41 patients with Vogt-Koyanagi-Harada disease (VKH disease) who had visited Seoul National University Hospital from 1986 to 1990 were reviewed. Twenty one patients were men and twenty patients were women. Extraocular manifestations included headache (64%), alopecia (34%), poliosis (24%), vitligo (12%), tinnitus (14%), and dysacousia (14%). Arden ratios in electro-oculogram (EOG) were low in the early stages of disease, and became improved with regaining vision. The amplitudes of electroretinogram (ERG), which were low in the early stage, recovered during medication in many cases. Visual prognosis was better if patients were treated with systemic steroid from the beginning. Factors contributing to recurrent or persistent inflammation despite of treatment included numerous extraocular manifestations and delayed treatment.
Alopecia ; Female ; Headache ; Humans ; Inflammation ; Male ; Prognosis ; Seoul ; Tinnitus ; Uveomeningoencephalitic Syndrome ; Visual Acuity

The clinical findings in the Vogt-Koyanagi-Harada syndrome ae reviewed and eight cases reported emphasizing the cutaneaus changes. The syndrome consists of symptoms of poliosis, vitiligo, alopecia, meningeal irritation sign, nontraumatic uveitis, and dysacousia. Meningeal or ocular symptons usually appear first, but in some patients thc cutanious changes have been observed beforc the uveitis. The etiology rernains unsettied, but an allergic mechanism or a virus infection is favaveci by most observers. Early diagnosis is important because ocular mobidity can be reduced significantly in some patients if treated in the early stages. During the course of treatment of our patients, corticosteroid is appeared to be the most effective drug for this uncertain etiologic syndrome and this fact may eventually support. the theory nf autoimmue mechanisn. The daily does of corticosteroid is prednisolone 60mg and the duration of administration is from 15 days to 2 months, after that the dose is graclually decreased in relation with the degree of symptoms. The ophthalrnologic symptoms were markedly improved 10 days after the administvation of prednisolonc. The purpose of this report is to emphasize the cutaneous findings in this syndrome, to point out that the cutaneous manifestations may lead to establishing tne diagnosis and on the basis of that, those patients can be received prompt, suitable treatment to avoid the grave ocular morbidity.
Alopecia ; Diagnosis ; Dronabinol ; Early Diagnosis ; Humans ; Prednisolone ; Uveitis ; Uveomeningoencephalitic Syndrome ; Vitiligo

Vogt-Koyanagi-Harada (VKH) syndrome is an idiopathic autoimmune disease involving melanocytes. The characteristic features are uveitis, meningismus, tinnitus, alopecia, vitiligo and poliosis, dependent upon the site of melanocyte location. Among the skin manifestations, alopecia usually appears as discrete, alopecic patches around the head. We report a case of fifty-year-old woman who presented with typical features of VKH syndrome, plus alopecia universalis and nail dystrophy.
Alopecia* ; Autoimmune Diseases ; Female ; Head ; Humans ; Melanocytes ; Meningism ; Skin Manifestations ; Tinnitus ; Uveitis ; Uveomeningoencephalitic Syndrome* ; Vitiligo